Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Aug
22
2012
United States' First Offshore Wind Farm Obtains Critical Federal Approval McDermott Will & Emery
Feb
20
2018
District Court Issues Opinion in Old Charter Bourbon False Advertising Class Action McDermott Will & Emery
Jun
28
2013
Claim Term Can Have Different Constructions Depending Upon Context In Patent Claims McDermott Will & Emery
Jul
21
2013
French Administrative Supreme Court (Conseil d'Etat) Orders Change to Rules Authorizing Hydrocarbon Exploration Drilling McDermott Will & Emery
Jun
6
2018
TTB to Allow Proprietors to Request Alternating Premise Variances for Storage of Tax- and Non-Tax-Determined Commodities McDermott Will & Emery
Jul
30
2013
Department of Justice Launches an Antitrust Investigation into Pressure Pumping Services Used in Hydraulic Fracturing McDermott Will & Emery
Sep
26
2013
IRS Issues Additional Guidance on When Construction Begins for Purposes of Production Tax Credit, Investment Tax Credit McDermott Will & Emery
Oct
1
2018
Recent Retailer Direct Shipping Opinion Illustrates Stakes in Upcoming Supreme Court Review McDermott Will & Emery
Jan
9
2014
Greenhouse Gas Limits for New Power Plants – Comments due to EPA (Environmental Protection Agency) by March 10, 2014 McDermott Will & Emery
Dec
12
2018
FDA Issues Real-World Evidence Framework for Drugs and Biologics McDermott Will & Emery
Oct
5
2014
A Warehouse Full of Unapproved Genetically-Modified Seeds; Now What?, Syngenta Seeds, Inc. v. Bunge North America, Inc. McDermott Will & Emery
Jun
3
2019
USDA Issues Opinion on Several Hemp-Related Provisions of the 2018 Farm Bill McDermott Will & Emery
Aug
25
2022
Can’t Dismiss Lanham Act Claim Based on FDCA Preemption McDermott Will & Emery
Aug
15
2019
Health Care Enforcement Quarterly Roundup | Q2 2019 McDermott Will & Emery
Jul
1
2015
No Induced Infringement Where Off-Label Use of a Drug Is Not “Inevitable” McDermott Will & Emery
Oct
11
2019
Overlapping Provisions in Major Healthcare Bills 2019 McDermott Will & Emery
Jan
13
2020
Eighth Circuit Strikes Down Multiple Missouri Alcohol Beverage Advertising Laws McDermott Will & Emery
Mar
3
2016
Ohio Court of Appeals Upholds a Successor Manufacturer’s Termination of a Distribution Franchise McDermott Will & Emery
Jun
21
2023
This Week in 340B: June 13 – 20, 2023 McDermott Will & Emery
Mar
5
2020
Antitrust Liability Risk When Listing Patents in Orange Book McDermott Will & Emery
Apr
18
2016
Red Stripe Prevails in Alcohol Beverage Labeling Class Action McDermott Will & Emery
Aug
24
2023
Tenth Circuit Reaffirms Preemption of State Pharmacy Network Regulations McDermott Will & Emery
Aug
31
2023
No Two Ways About It: No Disparagement ≠ Teaching Away, Free Samples ≠ Commercial Success McDermott Will & Emery
May
26
2016
Second Circuit Deals Blow to Off-Label Marketing Claims McDermott Will & Emery
Mar
26
2020
Crisis & Compliance: EU Competition Law During COVID-19 McDermott Will & Emery
Sep
28
2023
What’s Kühler Than Kühl? No Likelihood of Confusion McDermott Will & Emery
Apr
23
2020
Claimed Process Not Anticipated by Third-Party’s Prior Secret Use McDermott Will & Emery
Nov
7
2016
DEA Posts Significant Change to Registration Renewal McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins